Adam M Lippert, Daniel J Corsi, Rockli Kim, Robbee Wedow, Jinho Kim, Beza Taddess, S V Subramanian
{"title":"多基因和社会经济因素对中年早期尼古丁使用和心脏代谢健康的影响。","authors":"Adam M Lippert, Daniel J Corsi, Rockli Kim, Robbee Wedow, Jinho Kim, Beza Taddess, S V Subramanian","doi":"10.1093/ntr/ntae146","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Early mid-life is marked by accumulating risks for cardiometabolic illness linked to health-risk behaviors like nicotine use. Identifying polygenic indices (PGI) has enriched scientific understanding of the cumulative genetic contributions to behavioral and cardiometabolic health, though few studies have assessed these associations alongside socioeconomic (SES) and lifestyle factors.</p><p><strong>Aims and methods: </strong>Drawing on data from 2337 individuals from the United States participating in the National Longitudinal Study of Adolescent to Adult Health, the current study assesses the fraction of variance in five related outcomes-use of conventional and electronic cigarettes, body mass index (BMI), waist circumference, and glycosylated hemoglobin (A1c)-explained by PGI, SES, and lifestyle.</p><p><strong>Results: </strong>Regression models on African ancestry (AA) and European ancestry (EA) subsamples reveal that the fraction of variance explained by PGI ranges across outcomes. While adjusting for sex and age, PGI explained 3.5%, 2.2%, and 0% in the AA subsample of variability in BMI, waist circumference, and A1c, respectively (in the EA subsample these figures were 7.7%, 9.4%, and 1.3%). The proportion of variance explained by PGI in nicotine-use outcomes is also variable. Results further indicate that PGI and SES are generally complementary, accounting for more variance in the outcomes when modeled together versus separately.</p><p><strong>Conclusions: </strong>PGI are gaining attention in population health surveillance, but polygenic variability might not align clearly with health differences in populations or surpass SES as a fundamental cause of health disparities. We discuss future steps in integrating PGI and SES to refine population health prediction rules.</p><p><strong>Implications: </strong>Study findings point to the complementary relationship of PGI and socioeconomic indicators in explaining population variance in nicotine outcomes and cardiometabolic wellness. Population health surveillance and prediction rules would benefit from the combination of information from both polygenic and socioeconomic risks. Additionally, the risk for electronic cigarette use among users of conventional cigarettes may have a genetic component tied to the cumulative genetic propensity for heavy smoking. Further research on PGI for vaping is needed.</p>","PeriodicalId":19241,"journal":{"name":"Nicotine & Tobacco Research","volume":" ","pages":"1616-1625"},"PeriodicalIF":3.0000,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Polygenic and Socioeconomic Contributions to Nicotine Use and Cardiometabolic Health in Early Mid-Life.\",\"authors\":\"Adam M Lippert, Daniel J Corsi, Rockli Kim, Robbee Wedow, Jinho Kim, Beza Taddess, S V Subramanian\",\"doi\":\"10.1093/ntr/ntae146\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Early mid-life is marked by accumulating risks for cardiometabolic illness linked to health-risk behaviors like nicotine use. Identifying polygenic indices (PGI) has enriched scientific understanding of the cumulative genetic contributions to behavioral and cardiometabolic health, though few studies have assessed these associations alongside socioeconomic (SES) and lifestyle factors.</p><p><strong>Aims and methods: </strong>Drawing on data from 2337 individuals from the United States participating in the National Longitudinal Study of Adolescent to Adult Health, the current study assesses the fraction of variance in five related outcomes-use of conventional and electronic cigarettes, body mass index (BMI), waist circumference, and glycosylated hemoglobin (A1c)-explained by PGI, SES, and lifestyle.</p><p><strong>Results: </strong>Regression models on African ancestry (AA) and European ancestry (EA) subsamples reveal that the fraction of variance explained by PGI ranges across outcomes. While adjusting for sex and age, PGI explained 3.5%, 2.2%, and 0% in the AA subsample of variability in BMI, waist circumference, and A1c, respectively (in the EA subsample these figures were 7.7%, 9.4%, and 1.3%). The proportion of variance explained by PGI in nicotine-use outcomes is also variable. Results further indicate that PGI and SES are generally complementary, accounting for more variance in the outcomes when modeled together versus separately.</p><p><strong>Conclusions: </strong>PGI are gaining attention in population health surveillance, but polygenic variability might not align clearly with health differences in populations or surpass SES as a fundamental cause of health disparities. We discuss future steps in integrating PGI and SES to refine population health prediction rules.</p><p><strong>Implications: </strong>Study findings point to the complementary relationship of PGI and socioeconomic indicators in explaining population variance in nicotine outcomes and cardiometabolic wellness. Population health surveillance and prediction rules would benefit from the combination of information from both polygenic and socioeconomic risks. Additionally, the risk for electronic cigarette use among users of conventional cigarettes may have a genetic component tied to the cumulative genetic propensity for heavy smoking. Further research on PGI for vaping is needed.</p>\",\"PeriodicalId\":19241,\"journal\":{\"name\":\"Nicotine & Tobacco Research\",\"volume\":\" \",\"pages\":\"1616-1625\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2024-11-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nicotine & Tobacco Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/ntr/ntae146\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nicotine & Tobacco Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ntr/ntae146","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0
摘要
导言人到中年,心脏代谢疾病的风险不断累积,这与使用尼古丁等健康风险行为有关。多基因指数(PGI)的确定丰富了科学界对行为和心脏代谢健康的累积遗传贡献的认识,但很少有研究将这些关联与社会经济(SES)和生活方式因素一起进行评估:本研究利用参与美国青少年到成人健康纵向研究的 2,337 名美国人的数据,评估了 PGI、SES 和生活方式在五种相关结果(使用传统香烟和电子香烟、体重指数 (BMI)、腰围和糖化血红蛋白 (A1c) )中所占的变异比例:结果:非洲血统(AA)和欧洲血统(EA)子样本的回归模型显示,PGI 所解释的方差比例在不同结果中各不相同。在对性别和年龄进行调整后,PGI 对 AA 子样本中体重指数、腰围和 A1c 变异的解释率分别为 3.5%、2.2% 和 0%(对 EA 子样本的解释率分别为 7.7%、9.4% 和 1.3%)。在尼古丁使用结果中,PGI 所解释的变异比例也不尽相同。研究结果进一步表明,PGI 和 SES 通常是互补的,当它们一起建模时,与单独建模相比,PGI 能解释更多的结果差异:结论:PGI 在人群健康监测中越来越受到关注,但多基因变异性可能与人群的健康差异并不完全一致,也不可能超越 SES 成为健康差异的根本原因。我们讨论了整合 PGI 和 SES 以完善人群健康预测规则的未来步骤:研究结果表明,多基因指数(PGI)和社会经济指标在解释尼古丁结果和心脏代谢健康的人群差异方面具有互补关系。将多基因风险和社会经济风险的信息结合起来,将有利于人口健康监测和预测规则的制定。此外,传统香烟使用者使用电子香烟的风险可能与重度吸烟的累积遗传倾向有关。还需要进一步研究电子烟的 PGI。
Polygenic and Socioeconomic Contributions to Nicotine Use and Cardiometabolic Health in Early Mid-Life.
Introduction: Early mid-life is marked by accumulating risks for cardiometabolic illness linked to health-risk behaviors like nicotine use. Identifying polygenic indices (PGI) has enriched scientific understanding of the cumulative genetic contributions to behavioral and cardiometabolic health, though few studies have assessed these associations alongside socioeconomic (SES) and lifestyle factors.
Aims and methods: Drawing on data from 2337 individuals from the United States participating in the National Longitudinal Study of Adolescent to Adult Health, the current study assesses the fraction of variance in five related outcomes-use of conventional and electronic cigarettes, body mass index (BMI), waist circumference, and glycosylated hemoglobin (A1c)-explained by PGI, SES, and lifestyle.
Results: Regression models on African ancestry (AA) and European ancestry (EA) subsamples reveal that the fraction of variance explained by PGI ranges across outcomes. While adjusting for sex and age, PGI explained 3.5%, 2.2%, and 0% in the AA subsample of variability in BMI, waist circumference, and A1c, respectively (in the EA subsample these figures were 7.7%, 9.4%, and 1.3%). The proportion of variance explained by PGI in nicotine-use outcomes is also variable. Results further indicate that PGI and SES are generally complementary, accounting for more variance in the outcomes when modeled together versus separately.
Conclusions: PGI are gaining attention in population health surveillance, but polygenic variability might not align clearly with health differences in populations or surpass SES as a fundamental cause of health disparities. We discuss future steps in integrating PGI and SES to refine population health prediction rules.
Implications: Study findings point to the complementary relationship of PGI and socioeconomic indicators in explaining population variance in nicotine outcomes and cardiometabolic wellness. Population health surveillance and prediction rules would benefit from the combination of information from both polygenic and socioeconomic risks. Additionally, the risk for electronic cigarette use among users of conventional cigarettes may have a genetic component tied to the cumulative genetic propensity for heavy smoking. Further research on PGI for vaping is needed.
期刊介绍:
Nicotine & Tobacco Research is one of the world''s few peer-reviewed journals devoted exclusively to the study of nicotine and tobacco.
It aims to provide a forum for empirical findings, critical reviews, and conceptual papers on the many aspects of nicotine and tobacco, including research from the biobehavioral, neurobiological, molecular biologic, epidemiological, prevention, and treatment arenas.
Along with manuscripts from each of the areas mentioned above, the editors encourage submissions that are integrative in nature and that cross traditional disciplinary boundaries.
The journal is sponsored by the Society for Research on Nicotine and Tobacco (SRNT). It publishes twelve times a year.